1. Home
  2. CCEL vs NBY Comparison

CCEL vs NBY Comparison

Compare CCEL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.62

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
NBY
Founded
1989
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8M
31.6M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
CCEL
NBY
Price
$3.62
$1.95
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.3K
608.2K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
4.26%
N/A
EPS Growth
N/A
35.42
EPS
0.01
0.76
Revenue
$25,384,279.00
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$339.00
$2.57
Revenue Growth
9.76
N/A
52 Week Low
$2.72
$0.43
52 Week High
$5.52
$19.95

Technical Indicators

Market Signals
Indicator
CCEL
NBY
Relative Strength Index (RSI) 44.38 57.82
Support Level $3.18 $1.01
Resistance Level $4.04 $2.52
Average True Range (ATR) 0.20 0.26
MACD -0.02 0.11
Stochastic Oscillator 22.39 96.45

Price Performance

Historical Comparison
CCEL
NBY

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: